Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method
- PMID: 22140516
- PMCID: PMC3227604
- DOI: 10.1371/journal.pone.0028111
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method
Abstract
The worldwide spread of H1N1 avian influenza and the increasing reports about its resistance to the current drugs have made a high priority for developing new anti-influenza drugs. Owing to its unique function in assisting viruses to bind the cellular surface, a key step for them to subsequently penetrate into the infected cell, hemagglutinin (HA) has become one of the main targets for drug design against influenza virus. To develop potent HA inhibitors, the ZINC fragment database was searched for finding the optimal compound with the core hopping technique. As a result, the Neo6 compound was obtained. It has been shown through the subsequent molecular docking studies and molecular dynamic simulations that Neo6 not only assumes more favorable conformation at the binding pocket of HA but also has stronger binding interaction with its receptor. Accordingly, Neo6 may become a promising candidate for developing new and more powerful drugs for treating influenza. Or at the very least, the findings reported here may provide useful insights to stimulate new strategy in this area.
Conflict of interest statement
Figures





Similar articles
-
An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18431-18438. doi: 10.1073/pnas.2006893117. Epub 2020 Jul 20. Proc Natl Acad Sci U S A. 2020. PMID: 32690700 Free PMC article.
-
Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.Eur J Med Chem. 2016 Mar 3;110:376-88. doi: 10.1016/j.ejmech.2016.01.005. Epub 2016 Jan 8. Eur J Med Chem. 2016. PMID: 26866456
-
Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.J Med Chem. 2010 Jun 10;53(11):4441-9. doi: 10.1021/jm1002183. J Med Chem. 2010. PMID: 20476787
-
Fight Against H1N1 Influenza A Virus: Recent Insights Towards the Development of Druggable Compounds.Curr Med Chem. 2016;23(18):1802-17. doi: 10.2174/0929867323666160210124930. Curr Med Chem. 2016. PMID: 26861005 Review.
-
Investigational hemagglutinin-targeted influenza virus inhibitors.Expert Opin Investig Drugs. 2017 Jan;26(1):63-73. doi: 10.1080/13543784.2017.1269170. Epub 2016 Dec 14. Expert Opin Investig Drugs. 2017. PMID: 27918208 Review.
Cited by
-
Virtual screening, optimization, and identification of a novel specific PTP-MEG2 Inhibitor with potential therapy for T2DM.Oncotarget. 2016 Aug 9;7(32):50828-50834. doi: 10.18632/oncotarget.10341. Oncotarget. 2016. PMID: 27384997 Free PMC article.
-
RAACBook: a web server of reduced amino acid alphabet for sequence-dependent inference by using Chou's five-step rule.Database (Oxford). 2019 Jan 1;2019:baz131. doi: 10.1093/database/baz131. Database (Oxford). 2019. PMID: 31802128 Free PMC article.
-
Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone.Drug Des Devel Ther. 2014 Nov 7;8:2255-62. doi: 10.2147/DDDT.S70383. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25422585 Free PMC article.
-
Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies.Mol Divers. 2018 Aug;22(3):575-583. doi: 10.1007/s11030-018-9815-6. Epub 2018 Mar 13. Mol Divers. 2018. PMID: 29536226
-
Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors.Oncotarget. 2017 Jun 28;8(38):63187-63207. doi: 10.18632/oncotarget.18730. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28968981 Free PMC article.
References
-
- Naffakh N, van der Werf S. April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes and infection/Institut Pasteur. 2009;11:725–728. - PubMed
-
- Wang T, Wade RC. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. J Med Chem. 2001;44:961–971. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials